Trial intelligence / Profile preview

Dezocine and sufentanil interaction study for postoperative analgesia after gynecologic laparoscopic surgery

ChiCTR1900021270Phase 4Not yet recruiting

Sponsor
Tianjin Central Hospital of Obstetrics and Gynecology
Start
Jan 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of dezocine and sufentanil in postoperative pain (5 arms), sponsored by Tianjin Central Hospital of Obstetrics and Gynecology. Primary endpoints: VAS score and Interaction between dezocine and sufentanil. Planned start Jan 2019; status: not yet recruiting.

02

Drugs

dezocinesufentanil
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR1900021270.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900021270.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call